Published • loading... • Updated
AbbVie beats analyst estimates and posts one-day value jump bigger than Apogee deal size
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AbbVie beats analyst estimates and posts one-day value jump bigger than Apogee deal size
NEW YORK, July 2, 2026, 18:01 EDT AbbVie ended the session up 3.99% at $261.07 after hitting a 52-week high of $261.64. The gain tacked on roughly $17.8 billion in estimated equity, topping the Apogee deal’s $10.9 billion value. The stock closed above some average analyst targets. That puts extra focus on July 31 earnings.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
